Physiology, Acetylcholinesterase


Article Author:
Amy Trang


Article Editor:
Paras Khandhar


Editors In Chief:
Sherri Murrell


Managing Editors:
Avais Raja
Orawan Chaigasame
Khalid Alsayouri
Kyle Blair
Radia Jamil
Erin Hughes
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Navid Mahabadi
Hussain Sajjad
Steve Bhimji
Muhammad Hashmi
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Abbey Smiley
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beenish Sohail
Hajira Basit
Phillip Hynes
Sandeep Sekhon


Updated:
3/19/2019 4:53:35 PM

Introduction

Acetylcholinesterase (AChE) is a cholinergic enzyme primarily found at postsynaptic neuromuscular junctions, especially in muscles and nerves. It immediately breaks down or hydrolyzes acetylcholine (ACh), a naturally occurring neurotransmitter, into acetic acid and choline.[1] The primary role of AChE is to terminate neuronal transmission and signaling between synapses to prevent ACh dispersal and activation of nearby receptors. AChE is inhibited by organophosphates and is an important component of pesticides and nerve agents.

Issues of Concern

Organophosphates are acetylcholinesterase inhibitors with the potential for exposure and toxicity related to their use as pesticides. Due to widespread use, organophosphates are one of the most common causes of poisoning in the world from agricultural, accidental, or suicidal exposure.[2] Exposure to organophosphates may cause symptoms such as confusion, headache, impaired memory, and may have neurotoxic effects from repeated exposure. Irreversible acetylcholinesterase inhibitors used as insecticides or nerve agents in warfare pose significant toxicity. These agents induce a cholinergic crisis which includes any combination of the following:

  • Muscarinic effects, such as miosis, increased secretions (salivation, lacrimation), diarrhea, urination
  • Nicotinic effects, such as muscle fasciculations and neuromuscular blockade
  • Central effects: bradycardia

Organophosphate poisoning is treatable with atropine, an antimuscarinic, that reduces the effects of ACh surplus.[2] Atropine should be given initially at 2 to 5mg IV for adults and 0.05 mg/kg IV for children. Doubling the dose every 3 to 5 minutes until symptoms begin to cease is also appropriate if no relief is noted after the first dose.[3]

Alzheimer dementia (AD) is a prevalent disease that affects memory and cognition. The pathophysiology of cognitive impairment associated with AD has been attributed to a loss of cholinergic neurons.[4] Histologically, B-amyloid plaques and neurofibrillary tangles interrupt synaptic signaling, leading to neuronal cell death.[5] Since the 1990s, AChE inhibitors have shown some benefit for Alzheimer disease.[6] Inhibition of AChE results in a decreased breakdown and subsequent accumulation of acetylcholine. This excess acetylcholine leads to increased stimulation of muscarinic and nicotinic receptors, which provides some therapeutic relief for the memory deficits in AD.[4] AChE inhibitors have various levels of penetrance through the blood-brain barrier (BBB). Donepezil, rivastigmine, and tacrine are commonly used drugs for Alzheimer disease with good blood-brain barrier penetration. This activity is in contrast to the carbamate AChE inhibitors, neostigmine or pyridostigmine, which are charged quaternary structures at physiologic pH that prevent the crossing of the blood-brain barrier.[7] While the benefits of acetylcholine modulation therapy are promising, further studies are necessary due to the potential for accumulation of AChE, which may potentially interact with B-amyloid plaques and cause more neurotoxicity than B-amyloid alone.[4][8]

Cellular

As an enzyme, acetylcholinesterase exists as a monomer that often polymerizes into a dimer with a disulfide bond. Along with Van der Waals forces, two dimers may be linked to become tetramers. The tetramers assemble and bind themselves to what is described as “tails” made up of three strands. Chemically and immunologically, these tails structurally resemble collagen and may be broken down by collagenases. With an additional disulfide bond, the dimers of the tetramer link to each tail. A study by Brimijoin et al. describes the six combinations of AChE: three forms of the globular structure (monomers, dimers, tetramers) and three forms of tetramers (tailed, double, triple).[9] Globular AChE is labeled with a “G,” and tailed AChE is labeled with an “A.” Different forms have numerical subscripts associated with each letter to denote the number of their catalytic subunits. For example, a globular monomer is “G1,” and a globular tetramer is “G4”; meanwhile, a triple tetramer with a tail is “A12.”[9]

Development

Although the primary function of AChE is to terminate neural transmission, investigators have found that AChE also plays a role in neural development. Embryologically, AChE is intricately involved in the development of the nervous system and is expressed by developing neurons and during periods of axonal growth (a time in which enzymatic activity does not seem to be most important). In the peripheral nervous system of chicks, transient AChE activity was found to be locally present in the dorsal root ganglions. These findings suggest that during fetal development, AChE contributes to morphogenesis in addition to its main enzymatic function.[10]

Organ Systems Involved

Acetylcholinesterase is known to be distributed in nervous tissue such as the brainstem, cerebellum, peripheral and autonomic nervous systems. Skeletal muscle also contains AChE with distribution patterns seemingly related to the type of muscle (fast versus slow twitch) and their specific function.[9]

The presence and function of AChE on red blood cells is less commonly known. Blood group antigens reside on the outer lipid bilayer of red blood cells for convenient antibody recognition. In the same regard, AChE is also present on red blood cell membranes.[11]

Function

The neurotransmitter acetylcholine is released when a neural signal propagates and excites or activates a cellular membrane. Consequently, the ACh receptor undergoes a conformational change and the membrane releases calcium ions. These calcium ions play a role in exciting the fibers of nerves and muscles by triggering an additional change in phospholipids. Essentially, the downstream effect of a signal initiated with ACh results in amplification and propagation of the cellular signaling.[12]

Mechanism

The interaction of acetylcholinesterase with the substrate acetylcholine results in the breakdown, hydrolysis, and inactivation of acetylcholine and subsequent control of the amount of ACh at the synapse. AChE is a serine hydrolase that creates a tetrahedral intermediate through acid-base reactions with a catalytic triad (serine, histidine, acid residue).[8] Histidine allows for the transference of a proton between the oxygen molecules in serine and ACh, thereby removing choline to form a new acylated serine. When the acylated serine is deacylated, the regeneration of free AChE begins. In this reaction, aspartate stabilizes the protonated histidine, which releases acetic acid and a new, free enzyme. The interaction between amino acid residues (tyrosine, phenylalanine, tryptophan) that make up a peripheral anionic site influences the conformational binding of ACh to that site.[1]

Related Testing

Positron emission tomography (PET) imaging of cortical AChE activity in vivo has been used to measure the efficacy of dementia therapy. There are reports of decreased activity of acetylcholinesterase in patients with Alzheimer disease. By measuring AChE activity and using it to gauge cholinergic innervation expressed by axons and nerves, investigators may configure and assess the efficacy of cholinesterase inhibitors as it contributes to the management of Alzheimer disease.[13]

Pathophysiology

The human brain has a confluence of cholinergic neurons that project to various cortical areas. These neurons control attention, thinking, and processing of stimuli. Not only do cholinergic neurons span the forebrain, but they also encompass the brainstem and thalamus (such as the reticular nucleus) which are responsible for consciousness and attention. In the context of Alzheimer dementia as a neurodegenerative disease, these cholinergic neurons have defective projections that correlate with the classic symptoms of cognitive slowing and decline.[13] The disease is well known for declining short-term memory, atrophy of the cerebrum, B-amyloid plaques, tangles, and tau protein deposits.[1]

Clinical Significance

Patients with Alzheimer disease often receive treatment with acetylcholinesterase inhibitors that mitigate symptoms by hindering ACh turnover. In effect, lingering levels of ACh helps re-calibrate the neurotransmitter to appropriate and adequate levels.[5] Inhibition of AChE raises the concentration of ACh at the synaptic junction and allows for potentiation of the signal. This action ultimately reduces the amount of choline uptake and increases the number of muscarinic M2 receptors. In those treated with AChE inhibitors, a deceleration of the progression of the disease as well as increased attention span has been reported. However, no significant signs of increased short-term memory have been noted in the current literature.[1]

Despite the apparent benefit of AChE inhibitors for management of Alzheimer’s disease, recent studies have stated that the application of such inhibitors fails to address the pathology in its entirety. Nordberg et al. have found that some AChE inhibitors such as donepezil or galantamine show increased levels of AChE in CSF.[14] An imbalance of AChE can worsen Alzheimer’s dementia, as complexes of AChE-amyloid-B show higher levels of toxicity than amyloid-B plaques alone.[4] Such findings warrant a reassessment of current treatment options of the disease, as these drugs may have an underlying potential to worsen the pathologic state in Alzheimer disease.[8]      


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Physiology, Acetylcholinesterase - Questions

Take a quiz of the questions on this article.

Take Quiz
The active site of acetylcholinesterase contains large numbers of which amino acid?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following acetylcholine esterase (AChE) inhibitors cannot pass the blood-brain barrier (BBB)?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A farmer presents to the emergency department after prolonged exposure to insecticides used in his fields. Which of the following symptoms would you expect to see?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 92-year-old man with progressing cognitive decline for the past 7 years has trouble remembering names, streets and phone numbers that he once knew. Which of the following studies should his physician order to support his diagnosis?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
After finalizing a divorce with his partner, a 35-year-old male attempts suicide by drinking a bottle in his garage labeled "insecticide." He presents in the emergency department 2 hours later diaphoretic, salivating, and vomiting. His blood pressure is 182/90, heart rate is 55 beats per minute, and respiratory rate of 20 breaths/minute. He is afebrile with an oxygen saturation of 97% on room air. Physical exam shows 2-mm pupils. What is the most appropriate therapy for this patent?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A neurologist opens a PET image of a 97-year-old woman who presented with symptoms of progressive and increasing forgetfulness throughout the past 3 years. Which of the following in the PET image might support a diagnosis of Alzheimer disease in this patient?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Physiology, Acetylcholinesterase - References

References

McHardy SF,Wang HL,McCowen SV,Valdez MC, Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015). Expert opinion on therapeutic patents. 2017 Apr;     [PubMed]
Colović MB,Krstić DZ,Lazarević-Pašti TD,Bondžić AM,Vasić VM, Acetylcholinesterase inhibitors: pharmacology and toxicology. Current neuropharmacology. 2013 May;     [PubMed]
Konickx LA,Bingham K,Eddleston M, Is oxygen required before atropine administration in organophosphorus or carbamate pesticide poisoning? - A cohort study. Clinical toxicology (Philadelphia, Pa.). 2014 Jun;     [PubMed]
Lazarevic-Pasti T,Leskovac A,Momic T,Petrovic S,Vasic V, Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs. Current medicinal chemistry. 2017;     [PubMed]
Rees TM,Brimijoin S, The role of acetylcholinesterase in the pathogenesis of Alzheimer's disease. Drugs of today (Barcelona, Spain : 1998). 2003 Jan;     [PubMed]
McGleenon BM,Dynan KB,Passmore AP, Acetylcholinesterase inhibitors in Alzheimer's disease. British journal of clinical pharmacology. 1999 Oct;     [PubMed]
Pohanka M, Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity. International journal of molecular sciences. 2014 Jun 2;     [PubMed]
Soreq H,Seidman S, Acetylcholinesterase--new roles for an old actor. Nature reviews. Neuroscience. 2001 Apr;     [PubMed]
Brimijoin S, Molecular forms of acetylcholinesterase in brain, nerve and muscle: nature, localization and dynamics. Progress in neurobiology. 1983;     [PubMed]
Bigbee JW,Sharma KV,Gupta JJ,Dupree JL, Morphogenic role for acetylcholinesterase in axonal outgrowth during neural development. Environmental health perspectives. 1999 Feb;     [PubMed]
Bartels CF,Zelinski T,Lockridge O, Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism. American journal of human genetics. 1993 May;     [PubMed]
Leuzinger W, Structure and function of acetylcholinesterase. Progress in brain research. 1969;     [PubMed]
Herholz K, Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease. European journal of nuclear medicine and molecular imaging. 2008 Mar;     [PubMed]
Nordberg A,Darreh-Shori T,Peskind E,Soininen H,Mousavi M,Eagle G,Lane R, Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients. Current Alzheimer research. 2009 Feb;     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Nurse-Elder Adult Care. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Nurse-Elder Adult Care, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Nurse-Elder Adult Care, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Nurse-Elder Adult Care. When it is time for the Nurse-Elder Adult Care board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Nurse-Elder Adult Care.